OnKure Therapeutics (NASDAQ: OKUR) and Nautilus Biotechnology (NASDAQ: NAUT) are two small-cap medical companies drawing attention from investors. A comparative analysis reveals differences in institutional ownership,...
Artificial intelligence (AI) is poised to transform the biopharmaceutical industry, with expectations that a company will soon announce the first AI-designed antibody entering clinical trials. The...
